Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques

被引:48
作者
Ebalunode, Jerry Osagie [2 ]
Ouyang, Zheng [1 ]
Liang, Jie [1 ]
Zheng, Weifan [2 ]
机构
[1] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA
[2] N Carolina Cent Univ, BRITE Inst, Dept Pharmaceut Sci, Durham, NC 27707 USA
关键词
D O I
10.1021/ci700368p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Computationally efficient structure-based virtual screening methods have recently been reported that seek to find effective means to utilize experimental structure information without employing detailed molecular docking calculations. These tools can be coupled with efficient experimental screening technologies to improve the probability of identifying hits and leads for drug discovery research. Commercial software ROCS (rapid overlay of chemical structures) from Open Eye Scientific is such an example, which is a shape-based virtual screening method using the 3D structure of a ligand, typically from a bound X-ray costructure, as the query. We report here the development of a new structure-based pharmacophore search method (called Shape4) for virtual screening. This method adopts a variant of the ROCS shape technology and expands its use to work with an. empty crystal structure. It employs a rigorous computational geometry method and a deterministic geometric casting algorithm to derive the negative image (i.e., pseudoligand) of a target binding site. Once the negative image (or pseudoligand) is generated, an efficient shape comparison algorithm in the commercial OE SHAPE Toolkit is adopted to compare and match small organic molecules with the shape of the pseudoligand. We report the detailed computational protocol and its computational validation using known biologically active compounds extracted from the WOMBAT database. Models derived for five selected targets were used to perform the virtual screening experiments to obtain the enrichment data for various virtual screening methods. It was found that our approach afforded similar or better enrichment ratios than other related methods, often with better diversity among the top ranking computational hits.
引用
收藏
页码:889 / 901
页数:13
相关论文
共 50 条
[1]  
[Anonymous], 2006, MOE
[2]  
[Anonymous], CHEMOINFORMATICS DRU
[3]   CASTp: Computed atlas of surface topography of proteins [J].
Binkowski, TA ;
Naghibzadeh, S ;
Liang, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3352-3355
[4]   High-throughput crystallography for lead discovery in drug design [J].
Blundell, TL ;
Jhoti, H ;
Abell, C .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :45-54
[5]   A novel workflow for the inverse QSPR problem using multiobjective optimization [J].
Brown, Nathan ;
McKay, Ben ;
Gasteiger, Johann .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (05) :333-341
[6]   Docking and scoring - Theoretically easy, practically impossible? [J].
Coupez, B. ;
Lewis, R. A. .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (25) :2995-3003
[7]   Improved FlexX docking using FlexS-determined base fragment placement [J].
Cross, SSJ .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (04) :993-1001
[8]  
Delaunay B., 1934, B LACADEMIE SCI LURS, V6, P793
[9]   Key factors in the rising cost of new drug discovery and development [J].
Dickson, M ;
Gagnon, JP .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :417-429
[10]   The price of innovation: new estimates of drug development costs [J].
DiMasi, JA ;
Hansen, RW ;
Grabowski, HG .
JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) :151-185